Skip to main content
ODYY logo

ODYY · Odyssey Health, Inc. · Financials

Track ODYY — free
$0.01 At close · Oct 19
Market Cap
$706,780
Shares
100.97M
Volume · Oct 19 26.03K Avg daily vol (3M) 180.82K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$0
FY2020 Revenue FY2015–FY2020
Net Income
-$1.74M -106.9%
FY2025 Net Income FY2015–FY2025
Gross Margin
45.8% +34.6pp
FY2016 Gross Margin FY2015–FY2016
Operating Margin
-196.43% -135.8pp
FY2016 Operating Margin FY2015–FY2016
Diluted EPS
-$0.02 -100%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
-$347.39K +71.4%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
— — — — — — $0 $0 $0 $0 $37.45K $257.22K
— — — — — — $0 $0 $0 $0 $20.3K $228.49K
— — — — — — $0 $0 $0 $0 $17.15K $28.73K
— — — — — — — — — — 45.8% 11.17%
— $0 $55.17K $201.33K $1.32M $1.63M $20.24K $23.01M — — — —
$938.36K $1.02M $2.08M $2.12M $2.92M $4.79M $3.85M $23.36M $289K $167.58K $90.72K $184.63K
— — $1538 $3416 — — — $40.83K $10K — — —
$0 — $1538 $3416 $3416 $2374 $10.55K $10.55K $10.55K $10.55K $5138 $0
-$938.36K -$1.02M -$2.14M -$5.31M -$8.11M -$15.86M -$3.85M -$23.58M -$420.44K -$167.58K -$73.57K -$155.9K
— — — — — — — — — — -196.43% -60.61%
-$1.13M — -$2.14M -$5.31M -$8.1M -$15.86M -$3.84M -$23.57M -$409.89K -$157.02K -$68.43K -$155.9K
$1.09M $252.52K $518.48K $614.08K $836.29K $1.07M $502.19K $70.28K $62.67K $30.27K $12.55K $4800
-$20.14K -$10.01K $9265 $8677 — — — — — — — —
-$27.36K -$459.42K -$1.64M — — — — — — — — —
— $0 $0 $0 $0 $0 $0 $0 — — — —
-$3.57M -$1.74M -$842.32K -$5.92M -$8.44M -$16.88M -$4.35M -$23.43M -$483.12K -$197.84K -$86.12K -$160.7K
— — — — — — — — — — -229.94% -62.47%
— -$1.74M -$905.77K -$5.92M — — — — — — — —
USD/shares -$0.03 -$0.02 -$0.01 -$0.07 -$0.09 -$0.18 -$0.05 -$0.34 $0.00 $0.00 $0.00 $0.00
USD/shares -$0.03 -$0.02 -$0.01 -$0.07 -$0.09 -$0.18 — — — — — —
shares — 104.71M 97.06M 82.68M 89M 93.73M 87.12M 69.9M 117.13M 114.79M 114.75M 114.75M
shares — 104.71M 97.06M 82.68M 89M 93.73M — — — — — —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Convertible debt, including current maturities 2026-04-30 USD 4,816,493 10-Q filed 2026-06-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of convertible debt
USD 2,144,977
Other notes payable 2026-04-30 USD 400,000 10-Q filed 2026-06-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of other notes payable
USD 397,344
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.78×
EV/EBIT
—
P/E (TTM)
—

Peer medians compare against the 32 similar-size Medical Devices companies (of 155 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1626644 CUSIP 67612C102 Visit website Investor relations